Sign In
Buy KMTS
$28.35
+1.95 (+7.39%)
At Close: Aug 10, 2026
Kestra Medical Technologies . Common Stock Earnings Calls
Jul 30, 2026
(Upcoming)
| Release date | Sep 10, 2026 |
| EPS estimate | -$0.630 |
| EPS actual | - |
| Revenue estimate | 29.01M |
| Revenue actual | - |
| Expected change | +/- 7.29% |
Apr 30, 2026
-$0.670 (-13.56%)
| Release date | Jul 14, 2026 |
| EPS estimate | -$0.590 |
| EPS actual | -$0.670 |
| EPS Surprise | -13.56% |
| Revenue estimate | 26.479M |
| Revenue actual | 28.638M |
| Revenue Surprise | 8.15% |
Jan 31, 2026
-$0.610 (-1.67%)
| Release date | Mar 17, 2026 |
| EPS estimate | -$0.600 |
| EPS actual | -$0.610 |
| EPS Surprise | -1.67% |
| Revenue estimate | 22.871M |
| Revenue actual | 24.552M |
| Revenue Surprise | 7.35% |
Oct 31, 2025
-$0.620 (-4.36%)
| Release date | Dec 11, 2025 |
| EPS estimate | -$0.594 |
| EPS actual | -$0.620 |
| EPS Surprise | -4.36% |
| Revenue estimate | 22.872M |
| Revenue actual | 22.565M |
| Revenue Surprise | -1.34% |
Last 4 Quarters for Kestra Medical Technologies . Common Stock
Below you can see how KMTS performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Oct 31, 2025
Missed
| Release date | Dec 11, 2025 |
| Price on release | $24.97 |
| EPS estimate | -$0.594 |
| EPS actual | -$0.620 |
| EPS surprise | -4.36% |
| Date | Price |
|---|---|
| Dec 05, 2025 | $24.07 |
| Dec 08, 2025 | $24.53 |
| Dec 09, 2025 | $24.81 |
| Dec 10, 2025 | $24.55 |
| Dec 11, 2025 | $24.97 |
| Dec 12, 2025 | $26.22 |
| Dec 15, 2025 | $26.49 |
| Dec 16, 2025 | $27.00 |
| Dec 17, 2025 | $26.82 |
| 4 days before | 3.74% |
| 4 days after | 7.41% |
| On release day | 5.01% |
| Change in period | 11.43% |
Jan 31, 2026
Missed
| Release date | Mar 17, 2026 |
| Price on release | $21.14 |
| EPS estimate | -$0.600 |
| EPS actual | -$0.610 |
| EPS surprise | -1.67% |
| Date | Price |
|---|---|
| Mar 11, 2026 | $22.14 |
| Mar 12, 2026 | $19.02 |
| Mar 13, 2026 | $19.08 |
| Mar 16, 2026 | $19.26 |
| Mar 17, 2026 | $21.14 |
| Mar 18, 2026 | $19.58 |
| Mar 19, 2026 | $19.56 |
| Mar 20, 2026 | $19.10 |
| Mar 23, 2026 | $19.59 |
| 4 days before | -4.52% |
| 4 days after | -7.33% |
| On release day | -7.38% |
| Change in period | -11.52% |
Apr 30, 2026
Missed
| Release date | Jul 14, 2026 |
| Price on release | $24.18 |
| EPS estimate | -$0.590 |
| EPS actual | -$0.670 |
| EPS surprise | -13.56% |
| Date | Price |
|---|---|
| Jul 08, 2026 | $26.80 |
| Jul 09, 2026 | $26.69 |
| Jul 10, 2026 | $25.99 |
| Jul 13, 2026 | $24.76 |
| Jul 14, 2026 | $24.18 |
| Jul 15, 2026 | $24.62 |
| Jul 16, 2026 | $23.98 |
| Jul 17, 2026 | $24.42 |
| Jul 20, 2026 | $23.24 |
| 4 days before | -9.78% |
| 4 days after | -3.89% |
| On release day | 1.80% |
| Change in period | -13.28% |
Jul 30, 2026
(Upcoming)
| Release date | Sep 10, 2026 |
| Price on release | - |
| EPS estimate | -$0.630 |
| EPS actual | - |
| Date | Price |
|---|---|
| Aug 04, 2026 | $25.93 |
| Aug 05, 2026 | $25.06 |
| Aug 06, 2026 | $25.27 |
| Aug 07, 2026 | $26.40 |
| Aug 10, 2026 | $28.35 |
Kestra Medical Technologies . Common Stock Earnings Call Transcript Summary of Q2 2026
Unable to generate transcript summary.
Kestra Medical Technologies . Common Stock Earnings History
Earnings Calendar
FAQ
When is the earnings report for KMTS?
Kestra Medical Technologies, Ltd. Common Stock (KMTS) has scheduled its earnings report for Sep 10, 2026 before the markets open.
What is the KMTS price-to-earnings (P/E) ratio?
KMTS P/E ratio as of Aug 10, 2026 (TTM) is -10.91.
What is the KMTS EPS forecast?
The forecasted EPS (Earnings Per Share) for Kestra Medical Technologies, Ltd. Common Stock (KMTS) for the first fiscal quarter 2026 is -$0.630.
What are Kestra Medical Technologies, Ltd. Common Stock's retained earnings?
On its balance sheet, Kestra Medical Technologies, Ltd. Common Stock reported retained earnings of $28.64 million for the latest quarter ending Apr 30, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
